Medifast director Kiai Parsa buys $68,027 in company stock
What it means
- What to watch: The headline hangs on one number ($68,027) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $MED -0.90% in the latest session.
- Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.
Where the stock stands
$MED last traded at $12.15, -0.90% on the session. That puts it 9.7% shy of its 52-week high of $13.45 and 32% clear of its low of $9.22 — a little above the middle of the range. Over the year it has ranged 46% from low to high: a moderate band — it moves, but it rarely makes a scene. These are latest-session quotes, not live prices — the live tape is on the $MED page.
How much coverage it is getting
Nothing else on $MED in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Retail is a balancing act between shoppers' wallets and the company's margins: wages, credit and confidence drive the first, and discounting to win them can eat the second. Wook's supply-chain scanner has Consumer Discretionary reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$MED earnings in 2 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $MED page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $MED sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Consumer & Retail. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $MED. It carried $68,027, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.